Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma

NCT00202930 is registered in ClinicalTrials.gov with Jean M. Tersak, M.D. as lead sponsor.

NCT NCT00202930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00202930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Lead sponsor
Jean M. Tersak, M.D.
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2005
Completion date
February 5, 2009
Enrollment
4 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma, opsoclonus-myoclonus